Vishwas Setia
Vermögen: 10 Mio $ am 31.05.2026
Vermögen: 10 Mio $ am 31.05.2026
Vishwas Setia is currently Chief Financial Officer at MapLight Therapeutics, Inc. since 2024.
Formerly, Mr. Setia was an Investment Banking Summer Associate at Merrill Lynch & Co., Inc. in 2013.
Mr. Setia earned an MBA from Kellogg School of Management in 2014 and completed undergraduate studies at Delhi College of Engineering.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.05.2026 | 356.256 ( 0,84 % ) | 10 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Finanzdirektor/CFO | 18.03.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01.08.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Delhi College of Engineering
Delhi College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen